1. Home
  2. IVVD vs ABLV Comparison

IVVD vs ABLV Comparison

Compare IVVD & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • ABLV
  • Stock Information
  • Founded
  • IVVD 2020
  • ABLV 2015
  • Country
  • IVVD United States
  • ABLV China
  • Employees
  • IVVD N/A
  • ABLV N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • IVVD Health Care
  • ABLV
  • Exchange
  • IVVD Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • IVVD 63.4M
  • ABLV 51.4M
  • IPO Year
  • IVVD 2021
  • ABLV N/A
  • Fundamental
  • Price
  • IVVD $0.52
  • ABLV $0.93
  • Analyst Decision
  • IVVD Strong Buy
  • ABLV
  • Analyst Count
  • IVVD 3
  • ABLV 0
  • Target Price
  • IVVD $3.85
  • ABLV N/A
  • AVG Volume (30 Days)
  • IVVD 1.2M
  • ABLV 6.6K
  • Earning Date
  • IVVD 08-14-2025
  • ABLV 04-23-2025
  • Dividend Yield
  • IVVD N/A
  • ABLV N/A
  • EPS Growth
  • IVVD N/A
  • ABLV N/A
  • EPS
  • IVVD N/A
  • ABLV N/A
  • Revenue
  • IVVD $46,210,000.00
  • ABLV $128,932,647.00
  • Revenue This Year
  • IVVD $345.16
  • ABLV N/A
  • Revenue Next Year
  • IVVD $161.08
  • ABLV N/A
  • P/E Ratio
  • IVVD N/A
  • ABLV N/A
  • Revenue Growth
  • IVVD 1941.08
  • ABLV N/A
  • 52 Week Low
  • IVVD $0.35
  • ABLV $0.55
  • 52 Week High
  • IVVD $2.74
  • ABLV $1.87
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 32.49
  • ABLV 45.75
  • Support Level
  • IVVD $0.48
  • ABLV $0.77
  • Resistance Level
  • IVVD $0.65
  • ABLV $0.97
  • Average True Range (ATR)
  • IVVD 0.06
  • ABLV 0.05
  • MACD
  • IVVD -0.03
  • ABLV -0.00
  • Stochastic Oscillator
  • IVVD 11.35
  • ABLV 54.67

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: